863 (Topiramate Extended-Release 25 mg)

Pill with imprint 863 is White, Capsule-shape and has been identified as Topiramate Extended-Release 25 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Topiramate is used in the treatment of epilepsy; seizure prevention; lennox-gastaut syndrome; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 863

Topiramate Extended-Release

Imprint

863

Strength

25 mg

Color

White

Size

18.00 mm

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Carbonic anhydrase inhibitor anticonvulsants

Pregnancy Category

D - Positive evidence of risk

CSA Schedule

Not a controlled drug

Labeler / Supplier

Zydus Pharmaceuticals (USA) Inc.

Manufacturer

Cadila Healthcare Limited

National Drug Code (NDC)

68382-0863

Inactive Ingredients

alcohol, ammonia, butyl alcohol, microcrystalline cellulose, ethylcelluloses, ferrosoferric oxide, gelatin, hydrogenated castor oil, hypromelloses, isopropyl alcohol, polyethylene glycol, potassium hydroxide, povidone, propylene glycol, shellac, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triethyl citrate, water

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "863"

Theo-X

Theo-X

Theo-X

View more

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer